vernal keratoconjunctivitis - Articles and news items

Vekacia meets primary and secondary endpoints in VKC trial

Industry news / 11 May 2016 / Victoria White, Digital Content Producer

Vekacia demonstrated efficacy and tolerability vs placebo in the treatment of active, severe vernal keratoconjunctivitis (VKC) in paediatric patients…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+